Estimates Revisions Cytosorbents Corporation
Stocks
CTSO
US23283X3052
Advanced Medical Equipment & Technology
|
Delayed
Nasdaq
09:30:00 2026-10-05 am EDT
|
5-day change | 1st Jan Change | ||
| 3.850 USD | -4.94% |
|
-4.23% | -69.88% |
| Aug. 06 | Cytosorbents Corporation, Q2 2026 Earnings Call, Aug 06, 2026 | |
| Aug. 06 | Cytosorbents Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- CTSO Stock
- Consensus Cytosorbents Corporation
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
